Global Acute Lung Injury Market, Global Acute Lung Injury Market Report, Global Acute Lung Injury Market Trends, Global Acute Lung Injury Market Size

Acute Lung Injury Market Forecast 2025–2034: Where Businesses Should Invest Next

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Acute Lung Injury Market From 2025 To 2034?

The acute lung injury market has shown consistent expansion over recent years. It is projected to increase from $2.48 billion in 2024 to $2.59 billion by 2025, achieving a compound annual growth rate (CAGR) of 4.5%. Historically, this growth can be attributed to awareness campaigns, an increase in ICU admissions, factors such as smoking and air pollution, hospital-acquired infections, and efforts aimed at mortality rate reduction.

The acute lung injury market size is anticipated to experience consistent expansion over the next few years. It is projected to grow to $3.07 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 4.3%. This growth in the forecast period can be attributed to advancements in biologics and gene therapies, government funding and grants, the evolution of precision medicine, regenerative medicine and stem cell therapies, and global health policy reforms. Key trends for the forecast period encompass the development of biologic drugs, wearable and remote monitoring devices, inhalation-based therapies, CRISPR and gene editing technologies, and biosensors for real-time analysis.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20704&type=smp

Which Factors And Drivers Are Influencing The Acute Lung Injury Market In 2025?

The acute lung injury market is anticipated to expand as a result of the increasing occurrence of respiratory diseases. These conditions refer to a range of ailments that impact the lungs and other components of the respiratory system, causing breathing difficulties and reduced lung function. The rising prevalence of respiratory diseases can be attributed to factors such as higher air pollution, smoking, inactive lifestyles, an aging population, and the effects of viral infections. Respiratory diseases, including pneumonia, lead to acute lung injury by initiating severe inflammation and damaging the alveoli, which impairs gas exchange and causes respiratory distress. For instance, in September 2023, the Australian Bureau of Statistics reported that the death rate from influenza and pneumonia in the country increased from 31.9 per 100,000 people in 2021 to 42.6 per 100,000 people in 2022, signifying a considerable rise of approximately 33.54%. Therefore, the growing prevalence of respiratory diseases is propelling the growth of the acute lung injury market.

What Are The Leading Segments Analyzed In The Acute Lung Injury Market?

The acute lung injurymarket covered in this report is segmented –

1) By Injury Type: Direct Injury; Indirect Injury

2) By Therapy: Mechanical Ventilation; Pharmacotherapy; Fluid Management; Other Therapies

3) By End User: Hospitals; Clinics; Other End Users

Subsegments:

1) By Direct Injury: Trauma-Induced Acute Lung Injury; Aspiration Pneumonitis; Pneumonia-Related Acute Lung Injury; Inhalation Injury

2) By Indirect Injury: Sepsis-Related Acute Lung Injury; Shock-Induced Acute Lung Injury; Acute Lung Injury Due To Blood Transfusion; Acute Lung Injury Associated With Pancreatitis

How Are Emerging Market Trends Shaping The Acute Lung Injury Industry Landscape?

Major companies in the acute lung injury market are concentrating on developing innovative treatments, such as peptide therapies, to secure their market presence. Peptide treatment is defined as the application of short chains of amino acids, or peptides, as therapeutic agents for various medical ailments. For example, in November 2022, Zuventus Healthcare Ltd., an Indian healthcare enterprise, released Aviptadil to treat acute respiratory distress syndrome (ARDS). This therapy delivers several distinct advantages, including strong vasodilatory characteristics 50 times more effective than prostacyclin, a lung protection system that fosters surfactant generation by binding to alveolar type II cells, anti-inflammatory impacts that impede pro-inflammatory cytokines such as IL-6 and TNF-alpha, and an immunomodulatory influence to control pulmonary immune responses. Aviptadil has additionally exhibited clinical effectiveness in improving patient outcomes for severe viral-related ARDS.

Which Key Market Players Are Investing In Expansion And Innovation Of Acute Lung Injury Market?

Major companies operating in the acute lung injury market are Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Medtronic plc, Baxter International Inc., Ono Pharmaceutical Co Ltd., Aster DM Healthcare, Octapharma AG, Cartesian Therapeutics Inc., Vapotherm Inc., Stemedica Cell Technologies Inc., Implicit Bioscience Ltd., Apeiron Biologics AG, Faron Pharmaceuticals Ltd., Histocell Sociedad Limitada, Vasomune Therapeutics Inc, Windtree Therapeutics Inc., Qx Therapeutics Inc., Asklepion Pharmaceuticals LLC, ReAlta Life Sciences Inc., MediciNova Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/acute-lung-injury-global-market-report

Which Regional Markets Are Contributing Most To The Acute Lung Injury Industry Expansion?

North America was the largest region in the acute lung injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute lung injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Acute Lung Injury Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20704&type=smp

Browse Through More Reports Similar to the Global Acute Lung Injury Market 2025, By The Business Research Company

Lung Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Lung Cancer Diagnostic And Screening Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lung-cancer-diagnostic-and-screening-global-market-report

Small Cell Lung Cancer Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/small-cell-lung-cancer-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795